Abstract
Palforzia is an oral defatted peanut powder licensed for desensitisation of peanut allergy in 4–17 year‐olds. This article discusses the dosing procedure, clinical trial efficacy and adverse effects.
Cite
CITATION STYLE
APA
Chaplin, S. (2021). Palforzia for desensitisation of peanut allergy in children. Prescriber, 32(6), 33–34. https://doi.org/10.1002/psb.1928
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free